Literature DB >> 31209061

The Open Chromatin Landscape of Non-Small Cell Lung Carcinoma.

Zhoufeng Wang1, Kailing Tu2, Lin Xia2, Kai Luo2, Wenxin Luo1, Jie Tang2, Keying Lu2, Xinlei Hu2, Yijing He2, Wenliang Qiao3, Yongzhao Zhou1, Jun Zhang2, Feng Cao2, Shuiping Dai1, Panwen Tian1, Ye Wang1, Lunxu Liu4, Guowei Che4, Qinghua Zhou3, Dan Xie5, Weimin Li6.   

Abstract

Non-small cell lung carcinoma (NSCLC) is a major cancer type whose epigenetic alteration remains unclear. We analyzed open chromatin data with matched whole-genome sequencing and RNA-seq data of 50 primary NSCLC cases. We observed high interpatient heterogeneity of open chromatin profiles and the degree of heterogeneity correlated to several clinical parameters. Lung adenocarcinoma and lung squamous cell carcinoma (LUSC) exhibited distinct open chromatin patterns. Beyond this, we uncovered that the broadest open chromatin peaks indicated key NSCLC genes and led to less stable expression. Furthermore, we found that the open chromatin peaks were gained or lost together with somatic copy number alterations and affected the expression of important NSCLC genes. In addition, we identified 21 joint-quantitative trait loci (joint-QTL) that correlated to both assay for transposase accessible chromatin sequencing peak intensity and gene expression levels. Finally, we identified 87 regulatory risk loci associated with lung cancer-related phenotypes by intersecting the QTLs with genome-wide association study significant loci. In summary, this compendium of multiomics data provides valuable insights and a resource to understand the landscape of open chromatin features and regulatory networks in NSCLC. SIGNIFICANCE: This study utilizes state of the art genomic methods to differentiate lung cancer subtypes.See related commentary by Bowcock, p. 4808. ©2019 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31209061     DOI: 10.1158/0008-5472.CAN-18-3663

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

Review 1.  TLR/WNT: A Novel Relationship in Immunomodulation of Lung Cancer.

Authors:  Aina Martín-Medina; Noemi Cerón-Pisa; Esther Martinez-Font; Hanaa Shafiek; Antònia Obrador-Hevia; Jaume Sauleda; Amanda Iglesias
Journal:  Int J Mol Sci       Date:  2022-06-11       Impact factor: 6.208

2.  MAnorm2 for quantitatively comparing groups of ChIP-seq samples.

Authors:  Shiqi Tu; Mushan Li; Haojie Chen; Fengxiang Tan; Jian Xu; David J Waxman; Yijing Zhang; Zhen Shao
Journal:  Genome Res       Date:  2020-11-18       Impact factor: 9.043

3.  A pan-cancer analysis of CpG Island gene regulation reveals extensive plasticity within Polycomb target genes.

Authors:  Yueyuan Zheng; Guowei Huang; Tiago C Silva; Qian Yang; Yan-Yi Jiang; H Phillip Koeffler; De-Chen Lin; Benjamin P Berman
Journal:  Nat Commun       Date:  2021-04-30       Impact factor: 14.919

4.  ATAC-Seq identifies regions of open chromatin in the bronchial lymph nodes of dairy calves experimentally challenged with bovine respiratory syncytial virus.

Authors:  Dayle Johnston; JaeWoo Kim; Jeremy F Taylor; Bernadette Earley; Matthew S McCabe; Ken Lemon; Catherine Duffy; Michael McMenamy; S Louise Cosby; Sinéad M Waters
Journal:  BMC Genomics       Date:  2021-01-06       Impact factor: 3.969

5.  Integrated single-cell RNA sequencing analysis reveals distinct cellular and transcriptional modules associated with survival in lung cancer.

Authors:  Li Zhang; Yiming Zhang; Chengdi Wang; Ying Yang; Yinyun Ni; Zhoufeng Wang; Tingting Song; Menglin Yao; Zhiqiang Liu; Ningning Chao; Yongfeng Yang; Jun Shao; Zhidan Li; Ran Zhou; Li Chen; Dan Zhang; Yuancun Zhao; Wei Liu; Yupeng Li; Ping He; Jing-Wen Lin; Yuan Wang; Kang Zhang; Lu Chen; Weimin Li
Journal:  Signal Transduct Target Ther       Date:  2022-01-14

6.  HyperChIP: identification of hypervariable signals across ChIP-seq or ATAC-seq samples.

Authors:  Haojie Chen; Shiqi Tu; Chongze Yuan; Feng Tian; Yijing Zhang; Yihua Sun; Zhen Shao
Journal:  Genome Biol       Date:  2022-02-28       Impact factor: 13.583

7.  TENET 2.0: Identification of key transcriptional regulators and enhancers in lung adenocarcinoma.

Authors:  Daniel J Mullen; Chunli Yan; Diane S Kang; Beiyun Zhou; Zea Borok; Crystal N Marconett; Peggy J Farnham; Ite A Offringa; Suhn Kyong Rhie
Journal:  PLoS Genet       Date:  2020-09-14       Impact factor: 5.917

8.  Mechanical properties of nucleoprotein complexes determined by nanoindentation spectroscopy.

Authors:  Tatini Rakshit; Daniël P Melters; Emilios K Dimitriadis; Yamini Dalal
Journal:  Nucleus       Date:  2020-12       Impact factor: 4.197

9.  Deep cfDNA fragment end profiling enables cancer detection.

Authors:  Yulia V Zhitnyuk; Anastasia P Koval; Aleksandr A Alferov; Yanina A Shtykova; Ilgar Z Mamedov; Nikolay E Kushlinskii; Dmitriy M Chudakov; Dmitry S Shcherbo
Journal:  Mol Cancer       Date:  2022-01-21       Impact factor: 27.401

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.